|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159.6 USD | -4.58% |
|
-4.08% | +3.00% |
| Apr. 26 | Health Care Flat After Strong Earnings Week -- Health Care Roundup | DJ |
| Apr. 26 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
March 25 (Reuters) - AbbVie said on Monday it would acquire drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses.
(Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 159.6 USD | -4.58% | -4.08% | 283B | ||
| 22.31 USD | -0.80% | +2.25% | 69.53M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +3.00% | 283B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B | |
| -11.77% | 144B |
ABBVIE INC. 
